α‑hederin overcomes hypoxia‑mediated drug resistance in colorectal cancer by inhibiting the AKT/Bcl2 pathway.
Chen J, Xu J, Yang J, Zhan Y, Li S, Jia L, Wu W, Si X, Zhang D, Yu K, Yin P, Cao Y, Deng W, Xu K, Li W.
Chen J, et al. Among authors: li s, li w.
Int J Oncol. 2023 Mar;62(3):33. doi: 10.3892/ijo.2023.5481. Epub 2023 Jan 27.
Int J Oncol. 2023.
PMID: 36704835
Free PMC article.